Need more? Try out  Advanced Search (20+ criteria)»

Last Update

is this you? Claim your profile.

Wrong Shawn Scranton?

Shawn A. Scranton

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Background Information

Employment History

Director of Clinical Research

Uros , Ltd.


Vice President

Victory Pharma , Inc.


Vice President of Scientific Operations

Victory Pharma , Inc.


Vice President of Clinical Development

Victory Pharma , Inc.


Senior Director of Translational Medicine

Kalypsys , Inc.


Director , Clinical Development

Kalypsys , Inc.


Director of Clinical Development and Program Director of the SDX-101 Program

Salmedix , Inc.


Senior Manager of Medical Research

Dura Pharmaceuticals , Inc.


Senior Clinical Research Scientist

Dura Pharmaceuticals , Inc.


Principal Investigator On Industry

Baylor College of Medicine


Series of Academic Positions

Baylor College of Medicine


Assistant Professor

College of Pharmacy


Web References(11 Total References)


Situs Corporation - Press Release : 04/27/00

www.situscorp.com [cached]

Situs Corporation names Shawn Scranton director of Clinical ResearchSitus Corporation - Press Release : 04/27/00This is the Situs Corporation's LogoImportant Notice Home Executive Summary Markets SITUS CORPORATION NAMES SHAWN SCRANTON DIRECTOR OF CLINICAL RESEARCH Situs Corporation names Shawn Scranton director of Clinical Research SAN DIEGO, CA – January 24, 2001 – Situs Corporation, developer of a novel drug delivery platform for the administration of intravesical (bladder) drugs, today announced the appointment of Shawn A. Scranton Pharm.D. as Director of Clinical Research.Dr. Scranton brings to Situs experience in the pharmaceutical and clinical pharmacotherapy industries, according to Tate Scott, President and CEO of Situs. Most recently Dr. Scranton served as Senior Manager of Medical Research at Dura Pharmaceuticals.During his tenure at Dura he was responsible for study design, scientific conduct, and data analysis of numerous Phase I – IV clinical trials.Prior to that, he was an Assistant Professor at the University of Houston, College of Pharmacy and conducted clinical research in the area of cardiovascular pharmacodynamics.Dr. Scranton received his Doctor of Pharmacy from the University of the Pacific School of Pharmacy, where he later completed a post-doctoral fellowship in cardiovascular pharmacotherapy.He also completed a clinical pharmacy residency at Veterans Affairs Medical Center in San Diego and worked as a Clinical Pharmacist at several leading hospitals in Houston and San Diego. Situs is a combination specialty pharmaceutical and drug delivery device manufacturer pioneering an intravesical drug delivery platform.The Company's proprietary UROS Infusor is one of the most unique methods of drug delivery and provides a solution for the inadequacies of conventional therapies.In addition to the treatment of overactive bladder, other applications include chemotherapeutic agents for bladder cancer, hormones for genitourinary conditions and analgesics for pain.The Company is headquartered in Solana Beach, California. This press release contains forward-looking statements, such as projecting future performance of products and materials, which include some risk and uncertainty.


Victory Pharma - Management Team

www.victorypharma.com [cached]

Shawn A. Scranton, Pharm.
D., Vice President of Scientific Operations Dr. Scranton brings more than 19 years of clinical development experience to Victory. Most recently, he was Senior Director of Translational Medicine for Kalypsys, Inc., where he contributed to non-clinical, regulatory, and clinical strategies that enabled the successful opening of NCE INDs, and conducting Phase 1 clinical programs in neuropathic pain and metabolic disease. Formerly, Dr. Scranton was Director of Clinical Development and program director of the SDX-101 program for Salmedix, Inc., which was acquired by Cephalon. He began his commercial career as a Senior Clinical Research Scientist at Dura Pharmaceuticals after holding a series of academic positions at Baylor College of Medicine, where he served as a Principal Investigator on a number of industry and government-supported clinical trials. Dr. Scranton earned his Pharm.D. from the University of the Pacific School of Pharmacy, where he also completed a fellowship in cardiovascular pharmacology. He earned his B.A. in Animal Physiology from University of California, San Diego.


Situs Corporation - Press Release : 04/27/00

www.uros.com [cached]

Situs Corporation names Shawn Scranton director of Clinical ResearchSitus Corporation - Press_Release : 04/27/00This is the Situs Corporation's Logo.Situs Corporation names Shawn Scranton director of Clinical Research.SAN_DIEGO , CA – January 24 , 2001 , DATE : [ 01/24/2001 ]Situs Corporation , developer of a novel drug delivery platform for the administration of intravesical ( bladder ) drugs , today announced the appointment of Shawn A. Scranton Pharm.D. as Director of Clinical Research.Dr. Scranton brings to Situs experience in the pharmaceutical and clinical pharmacotherapy industries , according to Tate Scott , President and CEO of Situs.Most recently Dr. Scranton served as Senior_Manager of Medical Research at Dura Pharmaceuticals.During his tenure at Dura he was responsible for study design , scientific conduct , and data analysis of numerous Phase I – IV clinical trials.Prior_to that , he was an Assistant Professor at the University of Houston , College of Pharmacy and conducted clinical research in the area of cardiovascular pharmacodynamics.Dr. Scranton received his Doctor of Pharmacy from the University of the Pacific School of Pharmacy , where he later completed a post-doctoral fellowship in cardiovascular pharmacotherapy.He also completed a clinical pharmacy residency at Veterans Affairs Medical Center in San_Diego and worked as a Clinical Pharmacist at several leading hospitals in Houston and San_Diego.Situs is a combination specialty pharmaceutical and drug delivery device manufacturer pioneering an intravesical drug delivery platform.The Company's proprietary UROS Infusor is one of the most unique methods of drug delivery and provides a solution for the inadequacies of conventional therapies.In_addition to the treatment of overactive bladder , other applications include chemotherapeutic agents for bladder cancer , hormones for genitourinary conditions and analgesics for pain.The Company is headquartered in Solana_Beach , California.This press_release contains forward-looking statements , such_as projecting future performance of products and materials , which include some risk and uncertainty.


www.prnewswire.com

Victory Pharma, Inc. Announces Dr. Shawn A. Scranton as Vice President of Scientific OperationsVictory Pharma, Inc.Announces Dr. Shawn A. Scranton as Vice President of Scientific Operations SAN DIEGO, May 22 /PRNewswire/ -- Victory Pharma, Inc. announced today that Dr. Shawn A. Scranton has joined the Company as Vice President of Scientific Operations.Dr. Scranton will report to Matthew Heck, President, "Victory is pleased to have attracted a person of Dr. Scranton's we bring more pharmaceutical products through the pipeline, Dr. Scranton's contributions will be extremely valuable."Dr. Scranton observed, "Victory Pharma's proven management team and recent commercialization successes combined with high potential products currently under development were the key reasons I decided to join the Company." Dr. Scranton brings over 15 years of drug development experience to Victory Pharma.Most recently he was Senior Director of Translational Medicine for Kalypsys, Inc., where he contributed to nonclinical, regulatory, and clinical strategies that allowed for the successful opening of NCE INDs, and conduct of subsequent Phase I clinical programs in neuropathic pain and metabolic disease.Formerly, Dr. Scranton was Director of Clinical Development and Program Director of the SDX101 program for Salmedix, Inc., which was acquired by Cephalon, Inc. in 2005.Additionally, Dr. Scranton has also held academic positions at University of the Pacific, University of Houston, and Baylor College of Medicine. Dr. Scranton will be based in the Company's corporate headquarters in


www.pharmtech.com

San Diego, CA (May 22),Victory Pharma, Inc. (www.victorypharma.com) named Shawn A. Scranton vice-president of scientific operations.Scranton joins the company from Kalypsys, Inc., where he was senior director of translational medicine.He also held the position of director of clinical development and program director of the SDX101 program with Salmedix, Inc.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory